IP Library Granted Patent US 11,073,513
Granted Patent B2
US 11,073,513 · App. 15/206,751 · Granted Jul 27, 2021

Separating target analytes using alternating magnetic fields

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,073,513
App. No.
15/206,751
Granted
Jul 27, 2021
Kind
B2
Abstract

The invention generally relates to using magnetic particles and alternating magnet fields to separate a target analyte from a sample. In certain embodiments, methods of the invention involve contacting a sample with magnetic particles including first moieties specific for a target analyte, thereby forming target/particle complexes in the sample, flowing the sample through a channel including second moieties attached to at least one surface of the channel, applying alternating magnetic fields to the flowing sample to result in target/particle complexes being brought into proximity of the surface to bind the second moieties and unbound particles remaining free in the sample, binding the target/particle complexes to the second moieties, and washing away unbound particles and unbound analytes of the sample.

Claims (12)

1. A method for detecting a target analyte in a sample, the method comprising:

contacting a sample with magnetic particles comprising binding moieties specific for a target analyte;

flowing the sample through a channel including second moieties specific to the target analyte attached to at least one surface of the channel while applying alternating magnetic fields to capture, on the at least one surface of the channel, magnetic particles that are bound to said target analyte;

rinsing said channel to remove unbound components of said sample;

eluting bound magnetic particle/second moiety/target analyte complexes from the at least one surface of the channel; and

detecting the eluted magnetic particle/second moiety/target analyte complexes, wherein the magnetic particle/second moiety/target analyte complexes are not examined in situ on the at least one surface of the channel.

2. The method of claim 1 , wherein detecting comprises the use of one or more processes selected from the group consisting of lysis, hybridization, cytometry, nucleic acid testing (NAT), polymerase chain reaction (PCR), and nuclear magnetic resonance (NMR).

3. The method of claim 1 , wherein the target analyte is a bacterium.

4. The method of claim 1 , wherein the sample is human tissue or body fluid.

5. The method of claim 4 , wherein the body fluid is blood.

6. The method of claim 1 , wherein the binding moieties are selected from the group consisting of antibodies, receptors, aptamers, proteins, and ligands.

7. The method of claim 1 , wherein the binding moieties are antibodies.

Assignments (3)
MERGER Recorded Dec 21, 2016
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 041154/0174 →
CHANGE OF NAME Recorded Dec 21, 2016
From: NANOMR, INC.
To: DNA ELECTRONICS, INC.
Reel/Frame 041154/0202 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 21, 2016
From: DNA ELECTRONICS, INC.
To: DNAE GROUP HOLDINGS LIMITED
Reel/Frame 041154/0786 →